{
    "clinical_study": {
        "@rank": "3265", 
        "arm_group": [
            {
                "arm_group_label": "Regular care", 
                "arm_group_type": "No Intervention", 
                "description": "The control-group is treated according to \"care as usual\" with visits to physician every 6th month."
            }, 
            {
                "arm_group_label": "Nurse-led clinic", 
                "arm_group_type": "Experimental", 
                "description": "Nurse-led visits every 6th week, with structured person-centered care and evaluation of disease activity. If disease remission is not reached, pharmacological treatment including both short-term (intra-articular and oral steroids) and long-term alterations (DMARDs and biologics) is modified according to a predefined algorithm."
            }
        ], 
        "brief_summary": {
            "textblock": "Purpose: To compare a nurse-led clinic including person-centered care and tight control with\n      \"care as usual\" in patients with rheumatoid arthritis (RA) and moderate/ high disease\n      activity.\n\n      Project description: Study population: Patients with RA, 18-80 yrs old, with moderate/ high\n      Disease Activity Score of 28 joints (DAS28 > 3.8) and disease duration > 2 yrs in a 6-month\n      randomized controlled study with a 6 month open follow-up. Intervention group (N=60):\n      Nurse-led visits every 6th week, with structured person-centered care and evaluation of\n      disease activity. If disease remission is not reached, pharmacological treatment including\n      both short-term (intra-articular and oral steroids) and long-term alterations (DMARDs and\n      biologics) is modified according to a predefined algorithm. The control group (N=60) is\n      treated according to \"care as usual\" with visits to physician every 6th month. Outcome\n      measures: Primary outcome measure is change in Diseases Activity Score (DAS). Secondary\n      outcomes are quality of life, self-efficacy, disability, emotional well-being, pain,\n      fatigue, sleep and satisfaction."
        }, 
        "brief_title": "GotNet Study, The Gothenburg Nurse-led Tight Control Study", 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u226518 and <80 years of age\n\n          -  Signed and dated informed consent form before the start of any specific protocol\n             procedures\n\n          -  Fulfill the 1987 ACR criteria or the 2010 ACR/EULAR criteria for RA with disease\n             duration of  >2 years\n\n          -  Moderate to high disease activity (DAS28 >3.8)\n\n          -  \u22652 swollen joints\n\n        Exclusion Criteria:\n\n          -  Diagnosis of any other inflammatory arthritis\n\n          -  History of chronic infection, recent serious or life-threatening infection within 6\n             months\n\n          -  Concurrent malignancy, a history of malignancy or current or recent history of\n             severe, progressive, and/or uncontrolled renal, hepatic, hematological,\n             gastrointestinal, endocrine, pulmonary, cardiac, neurological or cerebral disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019901", 
            "org_study_id": "GotNet 2014 SU"
        }, 
        "intervention": {
            "arm_group_label": "Nurse-led clinic", 
            "intervention_name": "Nurse-led clinic", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Rheumatoid arthritis", 
            "Person-centered care", 
            "Tight control"
        ], 
        "lastchanged_date": "February 5, 2014", 
        "location": {
            "contact": {
                "email": "ulrika.bergsten@vgregion.se", 
                "last_name": "Ulrika Bergsten"
            }, 
            "facility": {
                "address": {
                    "city": "Gothenburg", 
                    "country": "Sweden"
                }, 
                "name": "Sahlgrenska University Hospital"
            }, 
            "investigator": {
                "last_name": "Lennart Jacobsson, Professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Controlled Study Evaluating the Efficacy of Person-centered, Tight Control Nurse-led Clinic of Patients With Established Rheumatoid Arthritis and Moderate to High Disease Activity Compared to Patients Receiving Regular Care", 
        "overall_contact": {
            "email": "lennart.jacobsson@gu.se", 
            "last_name": "Lennart Jacobsson, professor"
        }, 
        "overall_contact_backup": {
            "email": "ulrika.bergsten@vgregion.se", 
            "last_name": "Ulrika Bergsten, RN,PhD"
        }, 
        "overall_official": {
            "affiliation": "G\u00f6teborg University", 
            "last_name": "Lennart Jacobsson, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Swedish Data Inspection Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome constitute of DAS28, an index comprising the number of tender and swollen joints, patients global health assessment and erythrocyte sedimentation rate", 
            "measure": "Change in Disease activity score (DAS28)", 
            "safety_issue": "No", 
            "time_frame": "Baseline, week 26 and 50"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019901"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Vastra Gotaland Region", 
            "investigator_full_name": "Ulrika Bergsten", 
            "investigator_title": "RN, PHD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of patients with low Disease activity score (DAS28)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "measure": "Proportion of patients with remisson according to Disease activity score (DAS28)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "Measures functional status", 
                "measure": "Health assessment questionnaire (HAQ)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "Measures health status, allowing computation of cost-effectiveness", 
                "measure": "EuroQol (EQ-5D)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "Measures the patient's pain", 
                "measure": "Visual analogue scale for pain (VAS-pain)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "Measures the patient's fatigue.", 
                "measure": "Visual analogue scale fatigue (VAS-Fatigue)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "Measures the patient's general health.", 
                "measure": "Visual analogue scale general health (VAS-general health)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "Measures patients' perception of their knowledge, attitudes and behaviors about self-management skills", 
                "measure": "Effective Consumer Survey 17 (EC17)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "A patient-derived composite measure of the impact of the disease", 
                "measure": "Rheumatoid Arthritis Impact of Disease (RAID) score,", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }, 
            {
                "description": "Assessing patients' perceptions and expectation about medicines", 
                "measure": "The beliefs about medicines questionnaire (BMQ)", 
                "safety_issue": "No", 
                "time_frame": "Baseline,week 26 and 50"
            }, 
            {
                "description": "Measures satisfaction with rheumatology care", 
                "measure": "Numerical Rating Scale (NRS) about satisfaction with care", 
                "safety_issue": "No", 
                "time_frame": "Baseline, week 26 and 50"
            }
        ], 
        "source": "Vastra Gotaland Region", 
        "sponsors": {
            "collaborator": {
                "agency": "G\u00f6teborg University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Vastra Gotaland Region", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}